Arthur Cox advised Bristol Myers Squibb on the deal. Bristol Myers Squibb finalized a successful sale of its two Irish-authorised captive insurance undertakings, BMS International Insurance...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Bristol Myers Squibb on the offering, and Davis Polk & Wardwell advised the joint book-running managers and representatives of the underwriters. Bristol...
You must be a Standard 1 Year member to access this content.
Covington advised Bristol Myers Squibb on the transaction, while Cooley and Wilson Sonsini Goodrich & Rosati advised RayzeBio Inc. Goodwin advised Centerview Partners in its role...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis LLP advised Bristol Myers Squibb, while Skadden, Arps, Slate, Meagher & Flom LLP advised Mirat on the deal. Bristol Myers Squibb (NYSE: BMY)...
You must be a Standard 1 Year member to access this content.
McCarthy Tétrault is acting for Bristol-Myers Squibb and Pfizer. On January 12, 2021, Justice Zinn of Canada’s Federal Court released a decision in PM(NOC) litigation between...
You must be a Standard 1 Year member to access this content.
Cooley advised Turning Point Therapeutics, while Kirkland & Ellis advised Bristol Myers Squibb on the deal. Bristol Myers Squibb (NYSE:BMY), a global biopharmaceutical company, announced its...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised BMS, while White & Case advised LOTTE Corporation on the deal. Bristol Myers Squibb (BMS) executed the sale of its manufacturing facility in...
You must be a Standard 1 Year member to access this content.
Gowling WLG has advised Amphista Theraperutics on the deal. Baker Mackenzie advised Bristol Myers Squibb. The deal is a strategic collaboration and license agreement with Bristol...
You must be a Standard 1 Year member to access this content.
Kirkland & Ellis advised Bristol Myers Squibb on the offering. Bristol Myers Squibb (NYSE: BMY) executed its public offering of senior unsecured notes in a combined...
You must be a Standard 1 Year member to access this content.
YPOG advised the consortium of investors on the deal, alongside with KNPZ. CMS advised Cardior Pharmaceuticals GmbH. Cardior Pharmaceuticals GmbH has closed a €64 million series B...
You must be a Standard 1 Year member to access this content.
